These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 17933531)

  • 1. Phenylpiperidine-benzoxazinones as urotensin-II receptor antagonists: synthesis, SAR, and in vivo assessment.
    Luci DK; Ghosh S; Smith CE; Qi J; Wang Y; Haertlein B; Parry TJ; Li J; Almond HR; Minor LK; Damiano BP; Kinney WA; Maryanoff BE; Lawson EC
    Bioorg Med Chem Lett; 2007 Dec; 17(23):6489-92. PubMed ID: 17933531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-activity relationships of a novel series of urotensin II analogues: identification of a urotensin II antagonist.
    Chatenet D; Dubessy C; Boularan C; Scalbert E; Pfeiffer B; Renard P; Lihrmann I; Pacaud P; Tonon MC; Vaudry H; Leprince J
    J Med Chem; 2006 Nov; 49(24):7234-8. PubMed ID: 17125276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urotensin-II receptor ligands. From agonist to antagonist activity.
    Grieco P; Carotenuto A; Campiglia P; Marinelli L; Lama T; Patacchini R; Santicioli P; Maggi CA; Rovero P; Novellino E
    J Med Chem; 2005 Nov; 48(23):7290-7. PubMed ID: 16279788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonpeptide urotensin-II receptor antagonists: a new ligand class based on piperazino-phthalimide and piperazino-isoindolinone subunits.
    Lawson EC; Luci DK; Ghosh S; Kinney WA; Reynolds CH; Qi J; Smith CE; Wang Y; Minor LK; Haertlein BJ; Parry TJ; Damiano BP; Maryanoff BE
    J Med Chem; 2009 Dec; 52(23):7432-45. PubMed ID: 19731961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urantide mimics urotensin-II induced calcium release in cells expressing recombinant UT receptors.
    Camarda V; Song W; Marzola E; Spagnol M; Guerrini R; Salvadori S; Regoli D; Thompson JP; Rowbotham DJ; Behm DJ; Douglas SA; Calo' G; Lambert DG
    Eur J Pharmacol; 2004 Sep; 498(1-3):83-6. PubMed ID: 15363979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 2-Aminomethyl piperidines as novel urotensin-II receptor antagonists.
    Jin J; Wang Y; Wang F; Shi D; Erhard KF; Wu Z; Guida BF; Lawrence SK; Behm DJ; Disa J; Vaidya KS; Evans C; McMillan LJ; Rivero RA; Neeb MJ; Douglas SA
    Bioorg Med Chem Lett; 2008 May; 18(9):2860-4. PubMed ID: 18420409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5-HT2C receptor agonists with potential anorectic activity.
    Yoon G; Jeong HJ; Kim JJ; Cheon SH
    Arch Pharm Res; 2008 Aug; 31(8):989-94. PubMed ID: 18787786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A vasoactive peptide: urotensin II].
    Liu GQ; Zeng ZP
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2005 Aug; 27(4):525-8. PubMed ID: 16178453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human urotensin-II enhances plasma extravasation in specific vascular districts in Wistar rats.
    Gendron G; Simard B; Gobeil F; Sirois P; D'Orléans-Juste P; Regoli D
    Can J Physiol Pharmacol; 2004 Jan; 82(1):16-21. PubMed ID: 15052301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of novel Urotensin-II receptor antagonists with potent inhibition of U-II induced pressor response in mice.
    Tandon R; Soni A; Singh RK; Sodhi R; Seth MK; Sinha S; Sahdev S; Dhage G; Das B; Dastidar SG; Shriumalla RK; Yonesu K; Marumoto S; Nagayama T
    Eur J Pharmacol; 2020 Nov; 886():173391. PubMed ID: 32745605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new ligand for the urotensin II receptor.
    Camarda V; Guerrini R; Kostenis E; Rizzi A; Calò G; Hattenberger A; Zucchini M; Salvadori S; Regoli D
    Br J Pharmacol; 2002 Oct; 137(3):311-4. PubMed ID: 12237249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Three-dimensional model of the human urotensin-II receptor: docking of human urotensin-II and nonpeptide antagonists in the binding site and comparison with an antagonist pharmacophore model.
    Lescot E; Sopkova-de Oliveira Santos J; Colloc'h N; Rodrigo J; Milazzo-Segalas I; Bureau R; Rault S
    Proteins; 2008 Oct; 73(1):173-84. PubMed ID: 18409194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonpeptide Urotensin-II receptor agonists and antagonists: review and structure-activity relationships.
    Lescot E; Bureau R; Rault S
    Peptides; 2008 May; 29(5):680-90. PubMed ID: 18022732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of N-{1-[3-(3-oxo-2,3-dihydrobenzo[1,4]oxazin-4-yl)propyl]piperidin-4-yl}-2-phenylacetamide (Lu AE51090): an allosteric muscarinic M1 receptor agonist with unprecedented selectivity and procognitive potential.
    Sams AG; Hentzer M; Mikkelsen GK; Larsen K; Bundgaard C; Plath N; Christoffersen CT; Bang-Andersen B
    J Med Chem; 2010 Sep; 53(17):6386-97. PubMed ID: 20684563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ligand-supported purification of the urotensin-II receptor.
    Du AT; Onan D; Dinh DT; Lew MJ; Ziogas J; Aguilar MI; Pattenden LK; Thomas WG
    Mol Pharmacol; 2010 Oct; 78(4):639-47. PubMed ID: 20647393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitory effects of putative peptidic urotensin-II receptor antagonists on urotensin-II-induced contraction of cat isolated respiratory smooth muscle.
    Behm DJ; Ao Z; Camarda V; Aiyar NV; Johns DG; Douglas SA
    Eur J Pharmacol; 2005 Jun; 516(3):276-81. PubMed ID: 15975570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-activity relationship study on human urotensin II.
    Guerrini R; Camarda V; Marzola E; Arduin M; Calo G; Spagnol M; Rizzi A; Salvadori S; Regoli D
    J Pept Sci; 2005 Feb; 11(2):85-90. PubMed ID: 15635628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-activity relationship study of position 4 in the urotensin-II receptor ligand U-II(4-11).
    Marzola E; Camarda V; Batuwangala M; Lambert DG; Calo' G; Guerrini R; Trapella C; Regoli D; Tomatis R; Salvadori S
    Peptides; 2008 May; 29(5):674-9. PubMed ID: 17822806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of urotensin II, distribution of urotensin II, urotensin II-related peptide and UT receptor mRNAs in mouse: evidence of urotensin II at the neuromuscular junction.
    Dubessy C; Cartier D; Lectez B; Bucharles C; Chartrel N; Montero-Hadjadje M; Bizet P; Chatenet D; Tostivint H; Scalbert E; Leprince J; Vaudry H; Jégou S; Lihrmann I
    J Neurochem; 2008 Oct; 107(2):361-74. PubMed ID: 18710417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urotensin II: the old kid in town.
    Onan D; Hannan RD; Thomas WG
    Trends Endocrinol Metab; 2004; 15(4):175-82. PubMed ID: 15109617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.